Literature DB >> 10190288

Cancer invasion and tissue remodeling--cooperation of protease systems and cell types.

K Danø1, J Rømer, B S Nielsen, S Bjørn, C Pyke, J Rygaard, L R Lund.   

Abstract

Proteolytic degradation of the extracellular matrix plays a crucial role in both cancer invasion and non-neoplastic tissue remodeling processes. In human cancers the components of matrix degrading protease systems (uPA, uPAR, PAI-1 and MMPs) can be expressed by either the non-neoplastic stromal cells, the cancer cells or both. Studies of the prognostic impact of these components in human cancer and the effect of targeted gene inactivation on cancer metastasis in mice support the assumption that proteases promote cancer progression, independent of whether they are expressed by cancer cells or stromal cells. The pattern of expression of components of protease systems is usually very similar in different cases of the same type of cancer, while it varies between different types of cancer. There are intriguing similarities between the cellular expression pattern of components of protease systems seen in cancer invasion and in certain types of non-neoplastic tissue remodeling. We propose that cancer invasion can be viewed as tissue remodeling gone out of control. The stromal cell involvement in cancer invasion represents a new paradigm with important implications for cancer pathophysiology and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190288     DOI: 10.1111/j.1699-0463.1999.tb01534.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  65 in total

1.  Cellular activation of the self-quenched fluorescent reporter probe in tumor microenvironment.

Authors:  Alexei A Bogdanov; Charles P Lin; Maria Simonova; Lars Matuszewski; Ralph Weissleder
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

3.  Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression.

Authors:  Shoshana Greenberger; Irit Adini; Elisa Boscolo; John B Mulliken; Joyce Bischoff
Journal:  Angiogenesis       Date:  2010-09-25       Impact factor: 9.596

4.  Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.

Authors:  Shang-Ru Wu; Tai-Shan Cheng; Wen-Chi Chen; Hsin-Yi Shyu; Chun-Jung Ko; Hsiang-Po Huang; Chen-Hsin Teng; Chia-Hau Lin; Michael D Johnson; Chen-Yong Lin; Ming-Shyue Lee
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

5.  Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.

Authors:  Shihui Liu; Thomas H Bugge; Arthur E Frankel; Stephen H Leppla
Journal:  Methods Mol Biol       Date:  2009

6.  Solid tumor therapy by selectively targeting stromal endothelial cells.

Authors:  Shihui Liu; Jie Liu; Qian Ma; Liu Cao; Rasem J Fattah; Zuxi Yu; Thomas H Bugge; Toren Finkel; Stephen H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-29       Impact factor: 11.205

7.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

8.  Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

Authors:  Karin List; Roman Szabo; Alfredo Molinolo; Virote Sriuranpong; Vivien Redeye; Tricia Murdock; Beth Burke; Boye S Nielsen; J Silvio Gutkind; Thomas H Bugge
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

9.  The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.

Authors:  Niels Behrendt; Karin List; Peter A Andreasen; Keld Danø
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.

Authors:  Annika Jögi; Birgitte Rønø; Ida K Lund; Boye S Nielsen; Michael Ploug; Gunilla Høyer-Hansen; John Rømer; Leif R Lund
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.